HYDELTRASOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydeltrasol, and what generic alternatives are available?
Hydeltrasol is a drug marketed by Merck and is included in two NDAs.
The generic ingredient in HYDELTRASOL is prednisolone sodium phosphate. There are eighty-eight drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the prednisolone sodium phosphate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Hydeltrasol
A generic version of HYDELTRASOL was approved as prednisolone sodium phosphate by BAUSCH AND LOMB on July 29th, 1994.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDELTRASOL?
- What are the global sales for HYDELTRASOL?
- What is Average Wholesale Price for HYDELTRASOL?
Summary for HYDELTRASOL
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 36 |
| Clinical Trials: | 10 |
| Patent Applications: | 4,891 |
| DailyMed Link: | HYDELTRASOL at DailyMed |
Recent Clinical Trials for HYDELTRASOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Children's Oncology Group | Phase 2 |
| Children's Oncology Group | Phase 1/Phase 2 |
| National Cancer Institute (NCI) | Phase 1/Phase 2 |
US Patents and Regulatory Information for HYDELTRASOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | HYDELTRASOL | prednisolone sodium phosphate | INJECTABLE;INJECTION | 011583-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | HYDELTRASOL | prednisolone sodium phosphate | OINTMENT;OPHTHALMIC, OTIC | 011028-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
